Wolf W Asher, Jerath Maya R, Sperry Sarah L W, Shaheen Nicholas J, Dellon Evan S
Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Division of Allergy and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1272-9. doi: 10.1016/j.cgh.2013.12.034. Epub 2014 Jan 17.
BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) is an immune-mediated disorder. Food elimination is an established treatment for children, but data in adults are limited. We aimed to determine the response of adults with EoE to dietary therapy.
This was a retrospective cohort study using the University of North Carolina EoE database from 2006 to 2012. Subjects were age 18 and older, had EoE by consensus guidelines, and had undergone dietary therapy either with a targeted elimination diet or a 6-food elimination diet (SFED). Outcomes were symptomatic, endoscopic, and histologic improvement. Demographic, endoscopic, symptomatic, and laboratory predictors of response to dietary therapy were assessed.
Of 31 adults who underwent dietary therapy (mean age, 36 y; 48% male; 90% white; mean baseline eosinophil count, 78 eos/hpf), 22 had a targeted elimination diet and 9 had SFED. Symptoms improved in 71% (68% in targeted, 78% in SFED), and endoscopic appearance improved in 54% (53% in targeted, 56% in SFED). After dietary therapy, the mean eosinophil count decreased to 43 eos/hpf (P = .009). Eleven subjects (39%) responded with fewer than 15 eos/hpf (32% in targeted and 56% in SFED; P = .41). No clinical, endoscopic, or histologic factors predicted response to dietary therapy. Of the 11 responders, 9 underwent food re-introduction to identify trigger(s), and 4 (44%) reacted to dairy, 4 (44%) reacted to eggs, 2 (22%) reacted to wheat, 1 (11%) reacted to shellfish, 1 (11%) reacted to legumes, and 1 (11%) reacted to nuts.
Dietary elimination is a successful treatment modality for adults with EoE. Further research should emphasize which factors can predict effective dietary therapy.
嗜酸性粒细胞性食管炎(EoE)是一种免疫介导的疾病。食物排除疗法是治疗儿童EoE的既定方法,但针对成人的数据有限。我们旨在确定成人EoE患者对饮食疗法的反应。
这是一项回顾性队列研究,使用了北卡罗来纳大学2006年至2012年的EoE数据库。研究对象年龄在18岁及以上,根据共识指南确诊为EoE,并接受了针对性排除饮食或六食物排除饮食(SFED)的饮食疗法。观察指标包括症状、内镜检查和组织学改善情况。评估了饮食疗法反应的人口统计学、内镜、症状和实验室预测因素。
31例接受饮食疗法的成人(平均年龄36岁;48%为男性;90%为白人;平均基线嗜酸性粒细胞计数为78个/高倍视野)中,22例采用针对性排除饮食,9例采用SFED。71%的患者症状改善(针对性排除饮食组为68%,SFED组为78%),54%的患者内镜表现改善(针对性排除饮食组为53%,SFED组为56%)。饮食疗法后,平均嗜酸性粒细胞计数降至43个/高倍视野(P = 0.009)。11例患者(39%)的嗜酸性粒细胞计数降至15个/高倍视野以下(针对性排除饮食组为32%,SFED组为56%;P = 0.41)。没有临床、内镜或组织学因素能够预测对饮食疗法的反应。11例有反应的患者中,9例进行了食物重新引入以确定触发因素,4例(44%)对乳制品有反应,4例(44%)对鸡蛋有反应,2例(22%)对小麦有反应,1例(11%)对贝类有反应,1例(11%)对豆类有反应,1例(11%)对坚果有反应。
饮食排除疗法是治疗成人EoE的一种成功治疗方式。进一步的研究应着重于哪些因素能够预测有效的饮食疗法。